TriangleDISEASE & TREATMENT SETTING
XELODA: locally advanced Rectal cancer
Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.
Exact scope
( 1.1 ) perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy.
Broader topic: Rectal Cancer
- Source population
- Not part of this definition
- Disease extent
- locally-advanced
- Treatment line
- Not part of this definition
- Stage
- Not part of this definition
- Resectability
- Not part of this definition
Biomarkers, prior therapy and derivation
- molecular
- prior therapy
- derivation status
- source-attested
- derivation note
- Scoped from the FDA approved indication for XELODA (product label). Only dimensions stated in that wording are part of this definition.
- source wording
- ( 1.1 ) perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy.
Study evidence for this setting
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Engagement of Patients With Advanced Cancer
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Source relationships and population-mapping limitations
- bindings
- mappings
Download this complete draft source relationship record →
Preserved source evidence · Not medical advice